Filing Flows › Si-Bone (SIBN) › R&D spending
Si-Bone (SIBN) R&D spending by quarter
Si-Bone's R&D spending was $4.6M in Q3 2026 (third quarter 2026), -13% from Q2 2026. Over the last 7 quarters it ranged from $4.2M (Q1 2026) to $5.2M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.6M | -13% | +8% |
| Q2 2026 | $5.2M | +25% | +21% |
| Q1 2026 | $4.2M | -4% | -8% |
| Q4 2025 | $4.4M | +3% | — |
| Q3 2025 | $4.2M | -2% | — |
| Q2 2025 | $4.3M | -5% | — |
| Q1 2025 | $4.5M | — | — |
Q3 2026 at a glance
Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%, net loss $3.6M, operating cash flow $5.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Si-Bone's R&D spending?
Si-Bone's R&D spending was $4.6M in Q3 2026 (third quarter 2026), -13% from Q2 2026.
How has Si-Bone's R&D spending changed?
Over the last 7 quarters it ranged from $4.2M (Q1 2026) to $5.2M (Q2 2026).